Paper197922
Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents.
Lown JW and 3 others. Biochem Biophys Res Commun, 1977. Cited by 216 papers, by iCite.
Cite this record
ConductScience Library. Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents. Papers, record 197922. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/197922
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA, Circular | Major topic |
| DNA, Viral | Major topic |
| Daunorubicin | Major topic |
| Doxorubicin | Major topic |
| Binding Sites | |
| Nucleic Acid Conformation | |
| Oxidation-Reduction | |
| Superoxides |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 216 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34681173 | Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer Cells. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34681173 | PubMed |
| 32403427 | Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate Cancer. | Mar Drugs | 2020 | https://conductscience.org/library/papers/32403427 | PubMed |
| 31671612 | Successful Targeting of the Warburg Effect in Prostate Cancer by Glucose-Conjugated 1,4-Naphthoquinones. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31671612 | PubMed |
| 30465055 | Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions. | Naunyn Schmiedebergs Arch Pharmacol | 2019 | https://conductscience.org/library/papers/30465055 | PubMed |
| 27002730 | RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer. | AAPS J | 2016 | https://conductscience.org/library/papers/27002730 | PubMed |
| 24092333 | Enhancing cell nucleus accumulation and DNA cleavage activity of anti-cancer drug via graphene quantum dots. | Sci Rep | 2013 | https://conductscience.org/library/papers/24092333 | PubMed |
| 21859827 | Regulator of G protein signaling 6 mediates doxorubicin-induced ATM and p53 activation by a reactive oxygen species-dependent mechanism. | Cancer Res | 2011 | https://conductscience.org/library/papers/21859827 | PubMed |
| 16653223 | The Effect of 5OH-1,4-Naphthoquinone on Norway Spruce Seeds during Germination. | Plant Physiol | 1992 | https://conductscience.org/library/papers/16653223 | PubMed |
| 8037673 | One- and two-electron reduction of 2-methyl-1,4-naphthoquinone bioreductive alkylating agents: kinetic studies, free-radical production, thiol oxidation and DNA-strand-break formation. | Biochem J | 1994 | https://conductscience.org/library/papers/8037673 | PubMed |
| 7923547 | Hypoxia and drug resistance. | Cancer Metastasis Rev | 1994 | https://conductscience.org/library/papers/7923547 | PubMed |
| 7894775 | Epidermal growth factor, phorbol esters, and aurintricarboxylic acid are survival factors for MDA-231 cells exposed to adriamycin. | In Vitro Cell Dev Biol Anim | 1994 | https://conductscience.org/library/papers/7894775 | PubMed |
| 7765324 | Glutathione-related enzymes, glutathione and multidrug resistance. | Cytotechnology | 1993 | https://conductscience.org/library/papers/7765324 | PubMed |
| 7686469 | Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy. | Drugs | 1993 | https://conductscience.org/library/papers/7686469 | PubMed |
| 7076716 | Covalent protein binding of reactive adriamycin metabolites in rat liver and rat heart microsomes. | J Cancer Res Clin Oncol | 1982 | https://conductscience.org/library/papers/7076716 | PubMed |
| 7035210 | Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation. | Experientia | 1981 | https://conductscience.org/library/papers/7035210 | PubMed |
| 6353197 | The mechanism of action of quinone antibiotics. | Mol Cell Biochem | 1983 | https://conductscience.org/library/papers/6353197 | PubMed |
| 6324188 | Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6324188 | PubMed |
| 6295265 | Mechanism of action of dnacin B1, a new benzoquinoid antibiotic with antitumor properties. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6295265 | PubMed |
| 6285890 | Reactions of Adriamycin with haemoglobin. Superoxide dismutase indirectly inhibits reactions of the Adriamycin semiquinone. | Biochem J | 1982 | https://conductscience.org/library/papers/6285890 | PubMed |
| 3913602 | A chemical perspective on the anthracycline antitumor antibiotics. | Environ Health Perspect | 1985 | https://conductscience.org/library/papers/3913602 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/197922
GET https://conductscience.org/api/papers/v1/197922/cited_by?page=2